425 related articles for article (PubMed ID: 14676745)
1. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Senatori R; Dionisi B; Lippa P; Inghirami P
Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
3. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream in the treatment of anogenital warts in female patients.
Buck HW; Fortier M; Knudsen J; Paavonen J
Int J Gynaecol Obstet; 2002 Jun; 77(3):231-8. PubMed ID: 12065134
[TBL] [Abstract][Full Text] [Related]
7. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
9. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts.
Vilata JJ; Badia X;
Int J STD AIDS; 2003 Jan; 14(1):11-7. PubMed ID: 12590786
[TBL] [Abstract][Full Text] [Related]
11. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
[TBL] [Abstract][Full Text] [Related]
13. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
14. 5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.
Cusini M; Salmaso F; Zerboni R; Carminati G; Vernaci C; Franchi C; Locatelli A; Alessi E
Int J STD AIDS; 2004 Jan; 15(1):17-20. PubMed ID: 14769165
[TBL] [Abstract][Full Text] [Related]
15. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
17. [Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
Protasov AD; Lipatov IS; Kostinov MP; Tezikov YV; Shmitko AD; Pakhomov DV; Blagovidov DA; Zhestkov AV; Ryzhov AA; Vekhova EV
Urologiia; 2016 Nov; (5):47-51. PubMed ID: 28248020
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod in clinical practice.
Edwards L
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
[TBL] [Abstract][Full Text] [Related]
19. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
